Henry Schein (HSIC) Projected to Post Earnings on Tuesday

Key Points

• Henry Schein (HSIC) is set to release its Q2 2025 earnings report on August 5th, with analysts predicting earnings of $1.19 per share and revenue of $3.22 billion.
• In its last quarterly report on May 5th, Henry Schein exceeded earnings estimates with $1.15 EPS but fell short on revenue expectations, reporting $3.17 billion.
• Analysts have mixed ratings on the stock, with a consensus "Hold" rating and an average target price of $78.08 following recent adjustments from multiple firms.

Henry Schein (NASDAQ:HSIC - Get Free Report) will likely be posting its Q2 2025 quarterly earnings results before the market opens on Tuesday, August 5th. Analysts expect Henry Schein to post earnings of $1.19 per share and revenue of $3.22 billion for the quarter. Henry Schein has set its FY 2025 guidance at 4.800-4.940 EPS.

Henry Schein (NASDAQ:HSIC - Get Free Report) last issued its quarterly earnings results on Monday, May 5th. The company reported $1.15 earnings per share for the quarter, topping analysts' consensus estimates of $1.11 by $0.04. Henry Schein had a net margin of 3.21% and a return on equity of 14.87%. The company had revenue of $3.17 billion for the quarter, compared to the consensus estimate of $3.24 billion. During the same period in the previous year, the firm earned $1.10 EPS. The firm's quarterly revenue was down .1% on a year-over-year basis. On average, analysts expect Henry Schein to post $5 EPS for the current fiscal year and $5 EPS for the next fiscal year.

Henry Schein Price Performance

Shares of HSIC traded up $0.33 during midday trading on Friday, hitting $67.98. 1,557,873 shares of the company traded hands, compared to its average volume of 1,719,539. The company has a debt-to-equity ratio of 0.50, a current ratio of 1.38 and a quick ratio of 0.75. The stock has a 50-day moving average of $71.69 and a 200-day moving average of $71.35. The firm has a market cap of $8.27 billion, a P/E ratio of 21.24, a PEG ratio of 2.25 and a beta of 0.87. Henry Schein has a one year low of $60.56 and a one year high of $82.49.

Wall Street Analyst Weigh In

Several equities research analysts recently commented on the company. Wall Street Zen downgraded Henry Schein from a "buy" rating to a "hold" rating in a report on Thursday, April 17th. Evercore ISI lifted their price objective on Henry Schein from $72.00 to $78.00 and gave the stock an "in-line" rating in a report on Wednesday, July 9th. Baird R W downgraded Henry Schein from a "strong-buy" rating to a "hold" rating in a report on Monday, July 14th. Barrington Research reduced their price objective on Henry Schein from $90.00 to $86.00 and set an "outperform" rating for the company in a report on Tuesday, May 6th. Finally, Robert W. Baird restated a "neutral" rating and set a $72.00 price target (down from $82.00) on shares of Henry Schein in a research note on Monday, July 14th. Nine research analysts have rated the stock with a hold rating and four have issued a buy rating to the company's stock. According to MarketBeat, Henry Schein presently has a consensus rating of "Hold" and a consensus target price of $78.08.

Institutional Investors Weigh In On Henry Schein

A number of large investors have recently bought and sold shares of the business. Acadian Asset Management LLC bought a new position in Henry Schein in the first quarter valued at approximately $676,000. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its position in Henry Schein by 1.4% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 16,859 shares of the company's stock valued at $1,155,000 after acquiring an additional 229 shares during the period. Finally, AQR Capital Management LLC boosted its stake in shares of Henry Schein by 47.3% in the 1st quarter. AQR Capital Management LLC now owns 30,402 shares of the company's stock valued at $2,071,000 after purchasing an additional 9,756 shares during the last quarter. 96.62% of the stock is currently owned by institutional investors.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.